[Dehydroabietylguanidine (DAG), a semisynthetic broad spectrum antibiotic with a special effect on mycobacteria].
D000192:Actinomycetales / Q000187:drug effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000995:Antitubercular Agents / Q000494:pharmacology*; D003883:Arthrodermataceae / Q000187:drug effects; D002175:Candida / Q000187:drug effects; D003470:Culture Media; D004755:Enterobacteriaceae / Q000187:drug effects; D005260:Female; D005658:Fungi / Q000187:drug effects; D051379:Mice; D009161:Mycobacterium / Q000187:drug effects; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009615:Nocardia / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D051381:Rats; D013291:Streptococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D003470:Culture Media
Dehydroabietylguanidin (DAG), ein breitspektriges semisynthetisches Antibiotikum mit besonderer Wirkung gegen Mykobakterien.